Jump directly to
Jump directly to the main content
Jump directly to the search
Bayer Quarterly Statement Q3
2026
Wechsele die Sprache zu: Deutsch
Deutsch
de
Open search
Open main navigation
Close main navigation
Main menu
Key Events
Earnings Performance
Business Development by Division
Business Development by Division
Crop Science
Pharmaceuticals
Consumer Health
Financial Position
Financial Position
Statement of Cash Flows
Net financial debt
Future Perspectives
Condensed Consolidated Interim Financial Information
Condensed Consolidated Interim Financial Information
Condensed Consolidated Income Statements
Condensed Consolidated Statements of Financial Position
Condensed Consolidated Statements of Cash Flows
Goodwill, other intangible assets and property, plant and equipment
Legal Risks
Other Information
Other Information
Financial Calendar
Reporting Principles
Downloads
bayer.com
Other reports
Show more reports
Home
Search
Search
